Northwestern Mutual Wealth Management
VRNA

Northwestern Mutual Wealth Management’s Verona Pharma VRNA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-64
Closed -$925 – 3863
2024
Q2 		$925 Buy
+64
New +$934 ﹤0.01% 3221

Other funds holding VRNA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northwestern Mutual Wealth Management's VRNA Position: Q3 2024 in Review

Northwestern Mutual Wealth Management sold out of Verona Pharma (VRNA) in Q3 2024, closing a stake of 64 shares — an estimated $925 sold.

Northwestern Mutual Wealth Management first reported a position in VRNA in Q2 2024 and held it in 1 quarter. The position peaked at $925 in Q2 2024. 150 funds tracked by Wall St. Rank hold VRNA as of Q3 2024.

  • Northwestern Mutual Wealth Management reported no remaining Verona Pharma position as of Q3 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 64 Verona Pharma shares in Q3 2024, an estimated $925.
  • Northwestern Mutual Wealth Management first reported a position in Verona Pharma in Q2 2024 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Verona Pharma position peaked at $925 in Q2 2024.
  • 150 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.